The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Pleural Effusion in Connective Tissue Diseases

결체 조직 질환에서의 흉막 삼출

  • Lee, Joo-Hyun (Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases) ;
  • Kim, Tae-Hwan (Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases)
  • 이주현 (한양대학교 류마티스병원 류마티스내과) ;
  • 김태환 (한양대학교 류마티스병원 류마티스내과)
  • Published : 2011.08.01
⟨ Previous Next ⟩

Abstract

Connective tissue diseases represent an heterogenous group of immunologically mediated inflammatory disorders including multiorgan involvement, can affect pleura with various frequencies. Rheumatoid arthritis and systemic lupus erythematosus represent the most common immunological diseases that affect the pleural cavity. The clinical presentation, frequency, prognosis and response to therapy vary, depending on the pattern of involvement as well as on the underlying connective tissue diseases. In this article, we will review the pleural effusion caused by connective tissue diseases.

Keywords

References

  1. Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 2008;75:361-371. https://doi.org/10.1159/000119051
  2. Highland KB, Heffner JE, Pleural effusion in interstitial lung disease. Curr Opin Pulm Med 2004;10:390-396. https://doi.org/10.1097/01.mcp.0000134390.27904.a9
  3. Hakala M, Tiilikainen A, Hameenkorpi R, et al. Rheumatoid arthritis with pleural effusion includes a subgroup with autoimmune features and HLA-B8, Dw3 association. Scand J Rheumatol 1986;15:290-296. https://doi.org/10.3109/03009748609092595
  4. Light RW. Pleural disease. 3rd ed. Baltimore: Williams & Wilkins, 1995.
  5. Davies D. Pyopneumothorax in rheumatoid lung disease. Thorax 1966;21:230-235. https://doi.org/10.1136/thx.21.3.230
  6. Mizushima Y, Hoshi K, Shoji Y. IgE rheumatoid factor in a case of rheumatoid arthritis with pleuritis. J Rheumatol 1981;8:299-302.
  7. Koster FT, McGregor DD, Mackaness GB. The mediator of cellular immunity. II: migration of immunologically committed lymphocytes into inflammatory exudates. J Exp Med 1971;133:400-409. https://doi.org/10.1084/jem.133.2.400
  8. Alexandrakis MG, Coulocheri SA, Bouros D, Mandalaki K, Karkavitsas N, Eliopoulos GD. Evaluation of inflammatory cytokines in malignant and benign pleural effusions. Oncol Rep 2000;7:1327-1332.
  9. Jantz MA, Antony VB. Pathophysiology of the Pleura. Respiration 2008;75:121-133. https://doi.org/10.1159/000113629
  10. Amital A, Shitrit D, Adir Y. The lung in rheumatoid arthritis. Press Med 2011;40:e31-e48.
  11. Crestani B. The respiratory system in connective tissue disorders. Allergy 2005;60:715-734. https://doi.org/10.1111/j.1398-9995.2005.00761.x
  12. Halla JT, Schrohenloher RE, Volanakis JE. Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Ann Intern Med 1980;92:748-752. https://doi.org/10.7326/0003-4819-92-6-748
  13. Hunder GG, McDuffie FC, Hepper NG. Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis. Ann Intern Med 1972;76:357-363. https://doi.org/10.7326/0003-4819-76-3-357
  14. Balbir-Gurman A, Yigla M, Nahir AM, Braun-Moscovici Y. Rheumatoid pleural effusion. Semin Arthritis Rheum 2006;35:368-378. https://doi.org/10.1016/j.semarthrit.2006.03.002
  15. Torre O, Harari S. Pleural and pulmonary involvement in systemic lupus erythematosus. Presse Med 2011;40:e19-e29.
  16. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients. Am J Med 1981;71:791-798. https://doi.org/10.1016/0002-9343(81)90366-1
  17. Aiello M, Chetta A, Marangio E, Zompatori M, Olivieri D. Pleural involvement in systemic disorders. Curr Drug Targets Inflamm Allergy 2004;3:441-447. https://doi.org/10.2174/1568010042634604
  18. Breuer GS, Deeb M, Fisher D, Nesher G. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature. Semin Arthritis Rheum 2005;34:744-749. https://doi.org/10.1016/j.semarthrit.2004.11.003
  19. Khare V, Baethge B, Lang S, Wolf RE, Campbell GD Jr. Antinuclear antibodies in pleural fluid. Chest 1994;106:866-871. https://doi.org/10.1378/chest.106.3.866
  20. Brasington RD, Furst DE. Pulmonary disease in systemic lupus erythematosus. Clin Exp Rheumatol 1985;3:269-276.
  21. Sherer Y, Langevitz P, Levy Y, Fabrizzi F, Shoenfeld Y. Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin. Lupus 1999;8:324-327. https://doi.org/10.1191/096120399678847759
  22. Kaine JL. Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage. Ann Rheum Dis 1985;44:61-64. https://doi.org/10.1136/ard.44.1.61
  23. McKnight KM, Adair NE, Agudelo CA. Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus. Arthritis Rheum 1991;34:1483-1484.
  24. Winslow WA, Ploss LN, Loitman B. Pleuritis in systemic lupus erythematosus: its importance as an early manifestation in diagnosis. Ann Intern Med 1958;49:70-88. https://doi.org/10.7326/0003-4819-49-1-70
  25. Lee YH, Ji JD, Shim JJ, Kang KH, Song GG. Exudative pleural effusion and pleural leukocytoclastic vasculitis in limited scleroderma. J Rheumatol 1998;25:1006-1008.
  26. Thompson AE, Pope JE. A study of the frequency of pericardial and pleural effusions in scleroderma. Br J Rheumatol 1998;37:1320-1323. https://doi.org/10.1093/rheumatology/37.12.1320
  27. Lakhanpal S, Lie JT, Conn DL, Martin WJ 2nd. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;46:23-29. https://doi.org/10.1136/ard.46.1.23
  28. Miyata M, Fukaya E, Takagi T, et al. Two patients with polymyositis or dermatomyositis complicated with massive pleural effusion. Intern Med 1998;37:1058-1063. https://doi.org/10.2169/internalmedicine.37.1058
  29. Kawamata K, Haraoka H, Hirohata S, Hashimoto T, Jenkins RN, Lipsky PE. Pleurisy in primary Sjogren's syndrome: T cell receptor beta-chain variable region gene bias and local autoantibody production in the pleural effusion. Clin Exp Rheumatol 1997;15:193-196.
  30. Strimlan CV, Rosenow EC 3rd, Divertie MB, Harrison EG Jr. Pulmonary manifestations of Sjogren's syndrome. Chest 1976;70:354-361. https://doi.org/10.1378/chest.70.3.354
  31. Kashiwabara K, Kishi K, Narushima K, et al. Primary Sjogren's syndrome accompanied by pleural effusion. Nihon Kyobu Shikkan Gakkai Zasshi 1995;33:1325-1329.
  32. Zorab PA. Ankylosing spondylitis, a note on an early contribution from Guy's. Guys Hosp Rep 1961;110:96-98.
  33. Spencer DG, Park WM, Dick HM, Papazoglou SN, Buchanan WW. Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol 1979;6:305-315.
  34. Erkan L, Uzun O, Findik S, Atici AG, Ozkaya S. Isolated pleural and pericardial effusion in a patient with ankylosing spondylitis. Respir Med 2007;101:356-358. https://doi.org/10.1016/j.rmed.2006.04.028
  35. Prakash UB. Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998;19:733-746. https://doi.org/10.1016/S0272-5231(05)70113-1
  36. Sullivan WD, Hurst DJ, Harmon CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984;63:92-107.
  37. Bambery P, Sakhuja V, Behera D, Deodhar SD. Pleural effusion in Wegener's granulomatosis: report of five patients and a brief review of the literature. Scand J Rheumatol 1991;20:445-447. https://doi.org/10.3109/03009749109096825
  38. Tojima H, Kinoshita T, Kasahara Y, et al. A case of Wegener's granulomatosis with episcleritis, mediastinal lesions, and pleural effusion and without serum anti-neutrophil cytoplasmic antibodies. Nihon Kyobu Shikkan Gakkai Zasshi 1994;32:62-67.
  39. Diot E, Lavigne C, Renjard L, et al. Wegener's disease mimicking acute infectious pleurisy. Rev Pneumol Clin 2000;56:265-268.
  40. Blundell AG, Roe S. Wegener's granulomatosis presenting as a pleural effusion. BMJ 2003;327:95-96. https://doi.org/10.1136/bmj.327.7406.95
  41. Cheema GS, Quismorio FP Jr. Pulmonary involvement in adult-onset Still's disease. Curr Opin Pulm Med 1999;5:305-309. https://doi.org/10.1097/00063198-199909000-00007
  42. Mattiuzzo M, Del Forno M, Branca B, Moretti V, Pirisi M. Bilateral empyema caused by adult-onset Still's disease. Respiration 2001;68:88-90. https://doi.org/10.1159/000050469
  43. Nishio J, Koike R, Iizuka H, et al. A refractory case of adult-onset Still's disease. Nichon Rinsho Meneki Gakkai Kaishi 1997;20:191-198. https://doi.org/10.2177/jsci.20.191